1. Home
  2. HNRG vs FTRE Comparison

HNRG vs FTRE Comparison

Compare HNRG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hallador Energy Company

HNRG

Hallador Energy Company

HOLD

Current Price

$18.65

Market Cap

833.6M

Sector

Energy

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$10.50

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNRG
FTRE
Founded
1949
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
833.6M
1.5B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
HNRG
FTRE
Price
$18.65
$10.50
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$21.00
$15.39
AVG Volume (30 Days)
418.4K
2.0M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$404,394,000.00
$2,723,400,000.00
Revenue This Year
$18.72
$2.45
Revenue Next Year
N/A
$3.08
P/E Ratio
$19.46
N/A
Revenue Growth
N/A
1.00
52 Week Low
$8.38
$3.97
52 Week High
$24.70
$18.67

Technical Indicators

Market Signals
Indicator
HNRG
FTRE
Relative Strength Index (RSI) 47.61 34.34
Support Level $17.05 $9.35
Resistance Level $21.41 $11.46
Average True Range (ATR) 0.98 1.12
MACD -0.03 0.05
Stochastic Oscillator 26.63 34.24

Price Performance

Historical Comparison
HNRG
FTRE

About HNRG Hallador Energy Company

Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: